Business Context and Reporting Period
This Form 6-K, dated April 23, 2019, serves as a proxy statement for Camtek Ltd.'s Annual General Meeting of Shareholders scheduled for June 3, 2019. Camtek Ltd. is an Israeli company providing automated solutions for semiconductor fabrication and packaging. The filing details a strategic transaction with Chroma ATE Inc., a Taiwanese public company, and outlines governance changes including board re-elections and auditor appointments.
Key Financial Metrics and Transaction Details
The filing does not provide current period revenue, profit, or cash flow figures, as it is a proxy statement rather than a financial report. However, it details a significant capital transaction:
- Total Transaction Value: $74.3 million in total cash consideration to be received by Camtek and its controlling shareholder, Priortech Ltd.
- Private Placement: Camtek will issue 1,700,000 ordinary shares to Chroma for $16.15 million.
- Secondary Sale: Priortech will sell 6,117,440 shares to Chroma for approximately $58.12 million.
- Share Price: The transaction is based on a price of $9.50 per share, representing a 29% premium over the closing price on February 8, 2019.
- Post-Transaction Ownership: Chroma will hold approximately 20.5% of outstanding shares; Priortech will hold approximately 24%.
- Auditor Fees (FY 2018): Total fees paid to Somekh Chaikin were $263,988 ($249,437 for audit, $14,551 for tax).
Material Changes and Strategic Developments
The primary material change is the entry into definitive agreements with Chroma ATE Inc. on February 11, 2019, which includes:
- Technological Cooperation: A license agreement granting Chroma rights to Camtek's triangulation technology for non-semiconductor applications, with potential royalties and future manufacturing rights in Taiwan and China.
- Board Composition: Upon closing, the Board will expand to include two nominees from Chroma (Leo Huang and I-Shih Tseng), replacing two current directors (Eran Bendoly and Chezy Ofir) to maintain a seven-member board.
- Leadership Change: CEO Rafi Amit will resume the role of Chairman of the Board while continuing as CEO.
- Compensation Policy: Proposed amendments to increase the cap on annual cash bonuses for executives (excluding the CEO) from 4 to 6 monthly base salaries (On Target) and from 6 to 9 monthly base salaries (Total Cap).
Guidance, Outlook, and Risks
Outlook: Management views the transaction as strategically important for strengthening Camtek's presence in Asia, particularly Taiwan, and leveraging Chroma's capabilities in non-semiconductor markets. The transaction is expected to close by the end of the second quarter of 2019.
Risks and Contingencies:
- Regulatory Approvals: Closing is contingent on approvals from the Committee on Foreign Investment in the United States (CFIUS), the Taiwan Overseas Foreign Investment Commission, and the Central Bank of the Republic of China.
- Termination Risks: The agreement may be terminated if closing does not occur by June 30, 2019 (or 30 days later if only CFIUS approval is pending), or if a Material Adverse Effect occurs.
- Lock-up Period: Priortech and Chroma agreed to a two-year lock-up/no-sale period following the closing.
Investor Verification Checklist
- Verify the status of regulatory approvals, specifically CFIUS and Taiwanese foreign investment clearance, as these are closing conditions.
- Confirm the exact closing date of the transaction to assess the timing of cash inflow and board changes.
- Review the specific terms of the Technological Cooperation Agreement regarding royalty thresholds and caps to understand future revenue potential.
- Monitor the voting results for the Compensation Policy amendment, as it alters executive incentive structures.
- Check for any subsequent filings regarding the resignation of directors Eran Bendoly and Chezy Ofir and the appointment of Chroma nominees.